Beyond the hype: Balancing speed, security and value
Globally, the life sciences sector is working on improving operations and creating new value by transforming digitally. In a highly regulated sector where companies are often fragmented and siloed, transforming at scale can be difficult. For these reasons, it can be helpful for tech function leaders to compare their decision making against their peers in the sector and other industries.
The 乐鱼(Leyu)体育官网 global tech report: Life sciences insights examines the views of 123 senior-level life sciences technology function leaders from around the world that include chief digital officers, CIOs, CTOs, CISOs, chief AI officers and others.聽
This report contains valuable insights into how life sciences organizations are navigating the complexities of digital transformation and covers topics that include technology investment decision making, data, AI and cyber security.
Only 59 percent of life sciences respondents say their tech investment decision-making processes usually result in sound decisions that lead to valuable outcomes.
Life sciences leads all of the eight industries surveyed in prioritizing and investing in edge and quantum computing, VR/AR/XR, spatial computing, XaaS technology and modern delivery.
More than one-third of life sciences respondents say their organizations are using AI at scale and are achieving returns on investment.
61 percent of life sciences respondents worry that cyber security is frequently treated as a box-ticking exercise in staff training and isn鈥檛 embedded as extensively as it could be.
Read the full report to explore more insights and 乐鱼(Leyu)体育官网 life sciences technology specialist perspectives on the findings, and to obtain actionable recommendations for addressing life sciences organization technology challenges.
The insights in this report were derived from the聽乐鱼(Leyu)体育官网 global tech report 2024, a survey of 2,450 technology leaders from 26 countries across 8 industries: financial services, technology, retail and consumer packaged goods, industrial manufacturing, life sciences, healthcare, government and public sector, and energy. Survey respondents represented organizations with annual operating budgets or revenues above US$100M-plus.
Life sciences respondent demographics:聽123 life sciences technology function leaders were surveyed of which a significant portion (85 percent) held C-suite or department head, EVP, SVP or VP level positions. A strong majority (86 percent) of these respondents represented life sciences organizations with revenues of US$10B to US$50B-plus.
乐鱼(Leyu)体育官网 2025 Healthcare & Life Sciences Investment Outlook
Our annual in-depth examination of the healthcare and life sciences deal market explores 2024 and the year ahead.
Precision medicine 2.0: The multiomics era
Revolutionizing precision medicine by decoding disease mechanisms and personalizing treatments through advanced multiomics integration.
Our thinking: A new era of precision medicine
A new era of precision medicine: The unprecedented impact of generative AI across the precision medicine landscape